Clinical evolution of patients with respiratory allergic disease due to sensitisation to Alternaria alternata being treated with subcutaneous immunotherapy

Allergologia et Immunopathologia

Volumn 39, Issue 2, 2011, Pages 79-84

  Zapatero, L ^a   Martinez Canavate A ^b   Lucas, J M ^c   Guallar, I ^d   Torres, J ^e   Guardia, P ^f   de La Torre, F ^g   Pedemonte, C ^b  

^a HOSPITAL MATERNO INFANTIL GREGORIO MARAÑÓN   (Spain)

^b Hospital Materno Infantil de Granada   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^d H Infantil C S Miguel Servet   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^g ALK ABELLÓ   (Denmark)

Author keywords

Alternaria alternata; Asthma; Children; Quality of life; Rhinitis; Subcutaneous immunotherapy

Indexed keywords

ALLERGEN; ALTERNARIA ALTERNATA EXTRACT; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID DERIVATIVE; PANGRAMIN DEPOT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADOLESCENT; ALTERNARIA ALTERNATA; ARTICLE; ASTHMA; CHILD; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CONJUNCTIVITIS; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPEN STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUALITY OF LIFE; RESPIRATORY TRACT ALLERGY; RHINITIS; RHINOCONJUNCTIVITIS; SCHOOL CHILD; SENSITIZATION; SUBCUTANEOUS ALLERGEN SPECIFIC IMMUNOTHERAPY; VALIDITY;

ADOLESCENT; ALTERNARIA; ANTI-INFLAMMATORY AGENTS; ANTIGENS, PLANT; ASTHMA; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INJECTIONS, SUBCUTANEOUS; MALE; QUALITY OF LIFE; RESPIRATORY HYPERSENSITIVITY; SPAIN;

EID: 79955042185     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2010.03.011     Document Type: Article

References (23)

1. Gergen P.J., Turkeltaub P.C., Kovar M.G. The prevalence of allergic skin test reactivity to eight common aeroallergens in the U.S. population: results from the second National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 1987, 80:669-679.
2. Resano A., Sanz M.L., Oehling A. Sensitization to Alternaria and Cladosporium in asthmatic patients and its in vitro diagnostic confirmation. J Investing Allergol Clin Immunol 1998, 8:353-358.
3. D'Amato G., Chatzigeorgiou G., Corsico R., Gioulakas D., et al. Evaluation of the prevalence of skin pricks test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy. Allergy 1997, 52:711-716.
4. D'Amato G., Spieksma FThM. Aerobiologic and clinical aspects of mould allergy in Europe. Allergy 1995, 50:870-877.
5. Eggleston P.A., Rosenstreich D., Lynn H., Gergen P., et al. Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. Allergy Clin Immunol. 1998, 102:563-570.
6. Gergen P.J., Turkeltaub P.C. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol. 1992, 90:579-588.
7. Zureik M., Neukirch C., Leynaert B., Liard R., Bousquet J., Neukirch F. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ. 2002, 325:411-414. European Community Respiratory Health Survey.
8. Targonski P.V., Persky V.W., Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol. 1995, 95:955-961.
9. Downs S.H., Mitakakis T.Z., Marks G.B., Car N.G., Belousova E.G., Leuppi J.D., et al. Clinical importance of Alternaria exposure in children. Am J Respir Crit Care Med. 2001, 164:455-459.
10. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008, 63:8-160.
11. van Weel C., Bateman E.D., Bousquet J., Reid J., Grouse L., Schermer T., et al. Asthma management pocket reference 2008. Allergy 2008, 63:997-1004.
12. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 44: 5-42.
13. Position Paper. Immunotherapy. Malling HJ, Weeke B eds, Allergy 1993; 14 (48): 9-35.
14. Martínez-Cañavate A., Eseverri J.L., Ródenas R., Tabar A.I., Garde J., Torres J., et al. Evaluation of paediatric tolerance to an extract of Alternaria alternata under two treatment regimes. A multicentre study. Allergol et Immunopathol 2005, 33:138-141.
15. van Dellen Q., Stronks K., Bindels P., Öry F., Bruil J., van Aalderen W. Predictors of asthma control in children from different ethnic origins living in Amsterdam. Resp Med 2007, 101:779-785.
16. Juniper E.F., Guyatt G.H., Feeny D.H., Ferrie P.J., Griffith L.E., Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996, 5:35-46.
17. Horst M., Hejjaoui A., Horst V., Michel F.B., Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardised Alternaria extract. J Allergy Clin Immunol 1990, 85:460-472.
18. Bernardis P., Agnoletto M., Puccinelli P., Parmiani S., Pozzan M. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Invest Allergol Clin Immunol 1996, 6:55-62.
19. Tabar A.I., Lizaso M.T., García B.E., Echechipía S., Olaguibel J.M., Rodríguez A. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma. Invest Allergol Clin Inmunol 2000, 10:327-333.
20. Lizaso M.T., Martínez A., Asturias J.A., Algorta J., et al. Biological standardization and maximum tolerated dose estimation of an Alternaria alternate allergenic extract. J Invest Allergol Clin Immunol 2006, 16:94-103.
21. Tabar A.I., Lizaso M.T., García B.E., Gómez B., et al. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. Pediatr Allerg Immunol 2008, 19:67-75.
22. Lizaso M.T., Tabar A.I., García B.E., Gómez B., et al. Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters. Pediatr Allerg Immunol 2008, 19:76-81.
23. Martínez-Cañavate Burgos A., Valenzuela-Soria A., Rojo-Hernández A. Immunotherapy with Alternaria alternata: Present and future. Allergol Immunopathol 2007, 35:259-263.